Header Logo

Connection

JULIE BOOM to Male

Back to Details
This is a "connection" page, showing publications JULIE BOOM has written about Male.
JULIE BOOM
Connection Strength
0.623
Male
  1. Adherence to hepatitis B birth dose vaccine recommendations in two hospital systems in Houston. Vaccine. 2026 Apr 30; 80:128564.
    View in: PubMed
    Score: 0.039
  2. Arboviral Surveillance among Pediatric Patients with Acute Febrile Illness in Houston, Texas. Am J Trop Med Hyg. 2018 08; 99(2):413-416.
    View in: PubMed
    Score: 0.023
  3. Prevalence of Vaccine Hesitancy Among Expectant Mothers in Houston, Texas. Acad Pediatr. 2018 03; 18(2):154-160.
    View in: PubMed
    Score: 0.021
  4. Understanding the Financial Implications of Immunization Reminder/Recall in a Multipractice Pediatric Group. Acad Pediatr. 2017 04; 17(3):323-329.
    View in: PubMed
    Score: 0.019
  5. Parental report of vaccine receipt in children with autism spectrum disorder: Do rates differ by pattern of ASD onset? Vaccine. 2016 Mar 08; 34(11):1335-42.
    View in: PubMed
    Score: 0.019
  6. Variation in rotavirus vaccine coverage by provider location and subsequent disease burden. Pediatrics. 2015 Feb; 135(2):e432-9.
    View in: PubMed
    Score: 0.018
  7. The Texas Children's Hospital immunization forecaster: conceptualization to implementation. Am J Public Health. 2014 Dec; 104(12):e65-71.
    View in: PubMed
    Score: 0.018
  8. Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J Infect Dis. 2012 Oct; 206(8):1275-9.
    View in: PubMed
    Score: 0.015
  9. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010 Feb; 125(2):e199-207.
    View in: PubMed
    Score: 0.013
  10. Pediatric Vaccine Effectiveness Against Influenza Hospitalization and Outpatient Visits: 2021-2024. Pediatrics. 2026 May 01; 157(5).
    View in: PubMed
    Score: 0.010
  11. Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026. MMWR Morb Mortal Wkly Rep. 2026 Mar 12; 75(9):116-123.
    View in: PubMed
    Score: 0.010
  12. Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children. JAMA Pediatr. 2026 Mar 01; 180(3):314-324.
    View in: PubMed
    Score: 0.010
  13. Hospitalization Outcomes of Full-Term and Premature Children Aged Less Than 2?Years Hospitalized With RSV. Pediatrics. 2026 Feb 01; 157(2).
    View in: PubMed
    Score: 0.010
  14. Influenza Vaccine Effectiveness Among Children With and Without Underlying Conditions. Pediatrics. 2026 Feb 01; 157(2).
    View in: PubMed
    Score: 0.010
  15. Influenza Antiviral Use in Hospitalized Children Before and During the COVID-19 Pandemic. Pediatrics. 2026 Feb 01; 157(2).
    View in: PubMed
    Score: 0.010
  16. Viral Detection in Children <5?Years with Bronchiolitis, Pneumonia, and Croup, New Vaccine Surveillance Network, 2017-2023. J Pediatric Infect Dis Soc. 2025 Nov 01; 14(11).
    View in: PubMed
    Score: 0.009
  17. Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study. Clin Infect Dis. 2025 Oct 06; 81(3):623-633.
    View in: PubMed
    Score: 0.009
  18. Changes in Antiviral Prescribing for Children With Influenza in US Emergency Departments. JAMA Netw Open. 2025 Oct 01; 8(10):e2538729.
    View in: PubMed
    Score: 0.009
  19. Clinical Testing for COVID-19, Influenza, and RSV in Hospitalized Youths, 2016-2024. JAMA Netw Open. 2025 Sep 02; 8(9):e2531499.
    View in: PubMed
    Score: 0.009
  20. Human Metapneumovirus and Respiratory Syncytial Virus in Children: A Comparative Analysis. Pediatrics. 2025 Sep 01; 156(3).
    View in: PubMed
    Score: 0.009
  21. Acute Gastroenteritis Among Household Contacts of Children with Severe Norovirus Gastroenteritis, United States, 2011-2016. J Pediatric Infect Dis Soc. 2025 Jun 16; 14(6).
    View in: PubMed
    Score: 0.009
  22. Adenovirus Species in U.S. Children With Acute Respiratory Illness, 2016-2019. J Pediatric Infect Dis Soc. 2025 Jun 16; 14(6).
    View in: PubMed
    Score: 0.009
  23. Prevalence of human adenovirus in children with acute gastroenteritis in the New Vaccine Surveillance Network (NVSN) from 2016 to 2019. J Clin Virol. 2025 Aug; 179:105822.
    View in: PubMed
    Score: 0.009
  24. Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016-2020. Influenza Other Respir Viruses. 2025 Jun; 19(6):e70124.
    View in: PubMed
    Score: 0.009
  25. Epidemiology and genotypic diversity of rhinovirus in school-age children with acute respiratory illnesses seeking medical care. J Clin Virol. 2025 Aug; 179:105806.
    View in: PubMed
    Score: 0.009
  26. Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025. MMWR Morb Mortal Wkly Rep. 2025 May 08; 74(16):273-281.
    View in: PubMed
    Score: 0.009
  27. Enterovirus D68-Associated Respiratory Illness in Children. JAMA Netw Open. 2025 05 01; 8(5):e259131.
    View in: PubMed
    Score: 0.009
  28. The Epidemiology and Burden of Human Parainfluenza Virus Hospitalizations in US Children. J Pediatric Infect Dis Soc. 2025 Apr 08; 14(4).
    View in: PubMed
    Score: 0.009
  29. Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024. JAMA Pediatr. 2025 Feb 01; 179(2):179-187.
    View in: PubMed
    Score: 0.009
  30. Pediatric Clinical Influenza Disease by Type and Subtype 2015-2020: A Multicenter, Prospective Study. J Pediatric Infect Dis Soc. 2025 Jan 20; 14(1).
    View in: PubMed
    Score: 0.009
  31. Estimated Vaccine Effectiveness for Pediatric Patients With Severe Influenza, 2015-2020. JAMA Netw Open. 2024 12 02; 7(12):e2452512.
    View in: PubMed
    Score: 0.009
  32. Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024. MMWR Morb Mortal Wkly Rep. 2024 Nov 14; 73(45):1022-1029.
    View in: PubMed
    Score: 0.009
  33. Evaluation of a Modified Vesikari Severity Score as a Research Tool for Assessing Pediatric Acute Gastroenteritis. J Pediatric Infect Dis Soc. 2024 Nov 04; 13(10):547-550.
    View in: PubMed
    Score: 0.009
  34. On-time childhood vaccination before and during the COVID-19 pandemic in seven communities: Findings from the New Vaccine Surveillance Network. Vaccine. 2024 12 02; 42(26):126455.
    View in: PubMed
    Score: 0.009
  35. Rotavirus Vaccine Effectiveness Against Severe Acute Gastroenteritis: 2009-2022. Pediatrics. 2024 Oct 01; 154(4).
    View in: PubMed
    Score: 0.009
  36. Prevalence of SARS-CoV-2 in Children Identified by Preprocedural Testing at 5 US Children's Hospital Systems. Pediatr Infect Dis J. 2025 Jan 01; 44(1):47-53.
    View in: PubMed
    Score: 0.009
  37. COVID-19 Vaccine Hesitancy in Caregivers of Hospitalized Children From 2020 Through 2023. Hosp Pediatr. 2024 09 01; 14(9):701-713.
    View in: PubMed
    Score: 0.009
  38. Influenza C virus in U.S. children with acute respiratory infection 2016-2019. J Clin Virol. 2024 10; 174:105720.
    View in: PubMed
    Score: 0.009
  39. Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016-2022. Pediatrics. 2024 Jul 01; 154(1).
    View in: PubMed
    Score: 0.009
  40. Accuracy of Influenza ICD-10 Diagnosis Codes in Identifying Influenza Illness in Children. JAMA Netw Open. 2024 04 01; 7(4):e248255.
    View in: PubMed
    Score: 0.008
  41. Medical Costs of Respiratory Syncytial Virus-Associated Hospitalizations and Emergency Department Visits in Children Aged Younger Than 5?Years: Observational Findings from the New Vaccine Surveillance Network, 2016-2019. J Pediatr. 2024 08; 271:114045.
    View in: PubMed
    Score: 0.008
  42. Circulation of Rhinoviruses and/or Enteroviruses in Pediatric Patients With Acute Respiratory Illness Before and During the COVID-19 Pandemic in the US. JAMA Netw Open. 2023 02 01; 6(2):e2254909.
    View in: PubMed
    Score: 0.008
  43. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 14; 71(2):52-58.
    View in: PubMed
    Score: 0.007
  44. Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents. N Engl J Med. 2022 02 24; 386(8):713-723.
    View in: PubMed
    Score: 0.007
  45. Characteristics and Clinical Outcomes of Children and Adolescents Aged <18 Years Hospitalized with COVID-19 - Six Hospitals, United States, July-August 2021. MMWR Morb Mortal Wkly Rep. 2021 12 31; 70(5152):1766-1772.
    View in: PubMed
    Score: 0.007
  46. Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-November 2018-2020. MMWR Morb Mortal Wkly Rep. 2021 Nov 26; 70(47):1623-1628.
    View in: PubMed
    Score: 0.007
  47. Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 22; 70(42):1483-1488.
    View in: PubMed
    Score: 0.007
  48. Understanding Vaccine Hesitancy Among Parents of Children With Autism Spectrum Disorder and Parents of Children With Non-Autism Developmental Delays. J Child Neurol. 2021 09; 36(10):911-918.
    View in: PubMed
    Score: 0.007
  49. Acute Respiratory Illnesses in Children in the SARS-CoV-2 Pandemic: Prospective Multicenter Study. Pediatrics. 2021 08; 148(2).
    View in: PubMed
    Score: 0.007
  50. Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children: Multicenter Surveillance, United States, January-March 2020. J Pediatric Infect Dis Soc. 2020 Nov 10; 9(5):609-612.
    View in: PubMed
    Score: 0.007
  51. Vaccine Effectiveness Against Pediatric Influenza Hospitalizations and Emergency Visits. Pediatrics. 2020 11; 146(5).
    View in: PubMed
    Score: 0.007
  52. Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016. Pediatrics. 2020 07; 146(1).
    View in: PubMed
    Score: 0.007
  53. Evidence for Household Transmission of Rotavirus in the United States, 2011-2016. J Pediatric Infect Dis Soc. 2020 Apr 30; 9(2):181-187.
    View in: PubMed
    Score: 0.006
  54. Mining HPV Vaccine Knowledge Structures of Young Adults From Reddit Using Distributional Semantics and Pathfinder Networks. Cancer Control. 2020 Jan-Dec; 27(1):1073274819891442.
    View in: PubMed
    Score: 0.006
  55. Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016. JAMA Netw Open. 2019 09 04; 2(9):e1912242.
    View in: PubMed
    Score: 0.006
  56. Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018. MMWR Morb Mortal Wkly Rep. 2019 Mar 29; 68(12):277-280.
    View in: PubMed
    Score: 0.006
  57. Factors Associated With Rotavirus Vaccine Coverage. Pediatrics. 2019 02; 143(2).
    View in: PubMed
    Score: 0.006
  58. Early Usability Assessment of a Conversational Agent for HPV Vaccination. Stud Health Technol Inform. 2019; 257:17-23.
    View in: PubMed
    Score: 0.006
  59. Rotavirus Strain Trends During the Postlicensure Vaccine Era: United States, 2008-2013. J Infect Dis. 2016 09 01; 214(5):732-8.
    View in: PubMed
    Score: 0.005
  60. Molecular characterization of the first G24P[14] rotavirus strain detected in humans. Infect Genet Evol. 2016 09; 43:338-42.
    View in: PubMed
    Score: 0.005
  61. Epidemiologic Association Between FUT2 Secretor Status and Severe Rotavirus Gastroenteritis in Children in the United States. JAMA Pediatr. 2015 Nov; 169(11):1040-5.
    View in: PubMed
    Score: 0.005
  62. Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013. Clin Infect Dis. 2015 Dec 15; 61(12):1792-9.
    View in: PubMed
    Score: 0.005
  63. Innate Susceptibility to Norovirus Infections Influenced by FUT2 Genotype in a United States Pediatric Population. Clin Infect Dis. 2015 Jun 01; 60(11):1631-8.
    View in: PubMed
    Score: 0.005
  64. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis. 2013 Jul; 57(1):13-20.
    View in: PubMed
    Score: 0.004
  65. Detection of rotavirus antigenemia in routinely obtained serum specimens to augment surveillance and vaccine effectiveness evaluations. Pediatr Infect Dis J. 2010 Sep; 29(9):836-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.